Literature DB >> 8020830

Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma.

K R Lee1, P M Vacek, J L Belinson.   

Abstract

Ninety-three consecutive operative cases of myometrial invasive endometrioid adenocarcinoma of the uterus without evidence of extrauterine spread at surgery were reviewed to determine whether any histopathologic features other than those traditionally reported might predict recurrence. Recurrence was associated with traditionally analyzed features of deep myometrial invasion, high FIGO grade, vascular space invasion, and cervical stromal invasion as well as patient age. In addition, a diffuse pattern of myometrial invasion was associated with an increased risk for recurrence. Contrary to results from previous studies, no increased risk was seen with high nuclear grade or the presence of perivascular lymphocytic infiltrates. When adjusted for traditional parameters, perivascular lymphocytes and a tumor-host inflammatory response were associated with prolonged time to recurrence. A desmoplastic host response or residual adenomyosis were unrelated to recurrence.

Entities:  

Mesh:

Year:  1994        PMID: 8020830     DOI: 10.1006/gyno.1994.1158

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  How often does cervical involvement upstage patients with non-myoinvasive (otherwise stage 1A) endometrioid adenocarcinoma of the endometrium?

Authors:  Oluwole Fadare; Laurephile Desrosiers; Zhefu F Xiao; Sa A Wang
Journal:  Virchows Arch       Date:  2007-04-04       Impact factor: 4.064

2.  Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia.

Authors:  Wan Adnan Wan Nor Asyikeen; Ab Hamid Siti-Azrin; Nur Asyilla Che Jalil; Anani Aila Mat Zin; Nor Hayati Othman
Journal:  Malays J Med Sci       Date:  2016-12-07

3.  The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.

Authors:  Amy S Joehlin-Price; Kelsey E McHugh; Julie A Stephens; Zaibo Li; Floor J Backes; David E Cohn; David W Cohen; Adrian A Suarez
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 4.  How to approach the many faces of endometrioid carcinoma.

Authors:  Anais Malpica
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

5.  The pattern of myometrial invasion as a predictor of lymph node metastasis or extrauterine disease in low-grade endometrial carcinoma.

Authors:  Elizabeth Euscher; Patricia Fox; Roland Bassett; Hayma Al-Ghawi; Rouba Ali-Fehmi; Denise Barbuto; Bojana Djordjevic; Elizabeth Frauenhoffer; Insun Kim; Sun Rang Hong; Delia Montiel; Elizabeth Moschiano; Andres Roma; Elvio Silva; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

6.  L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma.

Authors:  Damiano Arciuolo; Antonio Travaglino; Angela Santoro; Giulia Scaglione; Nicoletta D'Alessandris; Michele Valente; Frediano Inzani; Rossella Accarino; Alessia Piermattei; Roberta Benvenuto; Antonio Raffone; Camilla Nero; Silvia Pelligra; Francesco Fanfani; Massimo Mascolo; Gian Franco Zannoni
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

7.  Predicting recurrence and metastasis risk of endometrial carcinoma via prognostic signatures identified from multi-omics data.

Authors:  Ling Li; Wenjing Qiu; Liang Lin; Jinyang Liu; Xiaoli Shi; Yi Shi
Journal:  Front Oncol       Date:  2022-08-19       Impact factor: 5.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.